½ÃÀ庸°í¼­
»óǰÄÚµå
1274358

¼¼°èÀÇ ¸ê±Õ Æ©ºê ¹ÐºÀ±â ½ÃÀå Á¶»ç º¸°í¼­ - »ê¾÷ ºÐ¼®, ±Ô¸ð, Á¡À¯À², ¼ºÀå, µ¿Çâ ¹× ¿¹Ãø(2023-2030³â)

Global Sterile Tubing Welders Market Research Report - Industry Analysis, Size, Share, Growth, Trends and Forecast 2023 to 2030

¹ßÇàÀÏ: | ¸®¼­Ä¡»ç: Value Market Research | ÆäÀÌÁö Á¤º¸: ¿µ¹® 145 Pages | ¹è¼Û¾È³» : 1-2ÀÏ (¿µ¾÷ÀÏ ±âÁØ)

    
    
    




¡Ø º» »óǰÀº ¿µ¹® ÀÚ·á·Î Çѱ۰ú ¿µ¹® ¸ñÂ÷¿¡ ºÒÀÏÄ¡ÇÏ´Â ³»¿ëÀÌ ÀÖÀ» °æ¿ì ¿µ¹®À» ¿ì¼±ÇÕ´Ï´Ù. Á¤È®ÇÑ °ËÅ並 À§ÇØ ¿µ¹® ¸ñÂ÷¸¦ Âü°íÇØÁֽñ⠹ٶø´Ï´Ù.

¸ê±Õ Æ©ºê ¹ÐºÀ±â ½ÃÀåÀÇ ¼¼°è ¼ö¿ä´Â 2023-2030³âÀÇ Á¶»ç ±â°£ µ¿¾È CAGR 8.92%·Î ¼ºÀåÇÏ¿© 2022³â 64¾ï 2,000¸¸ ´Þ·¯¿¡¼­ 2030³â¿¡´Â ¾à 127¾ï 2,000¸¸ ´Þ·¯ ±Ô¸ð¿¡ ´ÞÇÒ °ÍÀ¸·Î ÃßÁ¤µË´Ï´Ù.

¸ê±Õ Æ©ºê ¹ÐºÀ±â´Â Á¤¸ÆÁÖ¸Ó´Ï¿Í °°Àº ÀÇ·á±â±â¿¡¼­ Æ©ºê ±¸¼º ¿ä¼Ò °£ÀÇ ¹ÐÆóµÈ ¸ê±Õ ¿¬°áÀ» ½ÇÇöÇÏ´Â µ¥ »ç¿ëµÇ´Â ÀåºñÀÔ´Ï´Ù. ÀÇ·á±â±âÀÇ ¹«±Õ¼ºÀ» À¯ÁöÇϰí ȯÀÚÀÇ ¾ÈÀüÀ» º¸ÀåÇϱâ À§ÇØ ÀÌ ¿ëÁ¢±â¸¦ ÅëÇÑ ¿¬°áÀÌ Áß¿äÇÕ´Ï´Ù. ¸ê±Õ Æ©ºê ¹ÐºÀ±â´Â ¿­, ¾Ð·Â ¶Ç´Â µÎ °¡Áö ¸ðµÎ¸¦ »ç¿ëÇÏ¿© ¿¬°áºÎ¸¦ Çü¼ºÇÕ´Ï´Ù. ¾ö°ÝÇÑ ¸ê±Õ ¹× û°á ¿ä±¸ »çÇ×À» ÃæÁ·Çϵµ·Ï ¼³°èµÇ¾úÀ¸¸ç ÀϹÝÀûÀ¸·Î ¼ö¼ú½Ç ¹× Ŭ¸° ·ë°ú °°Àº ¹«±Õ ȯ°æ¿¡¼­ »ç¿ëµË´Ï´Ù. ¸ê±Õ Æ©ºê ¹ÐºÀ±â´Â ÀÇ·á±â±â Á¦Á¶ °øÁ¤ÀÇ Áß¿äÇÑ ±¸¼º ¿ä¼ÒÀ̸ç ÀÇ·á±â±âÀÇ ¾ÈÀü¼º°ú À¯È¿¼ºÀ» º¸ÀåÇÏ´Â µ¥ Áß¿äÇÑ ¿ªÇÒÀ»ÇÕ´Ï´Ù. ÀÌ ¿ëÁ¢±â´Â ¾à¹° Åõ¿©, ¼ö¾× ÁÖÀÔ, ¼öÇ÷ µî ´Ù¾çÇÑ ÀÇ·á ¿ëµµ¿¡ »ç¿ëµË´Ï´Ù. Àü¹ÝÀûÀ¸·Î ¸ê±Õ Æ©ºê ¹ÐºÀ±â´Â ¾ÈÀüÇϰí È¿°úÀûÀÎ ÀÇ·á±â±â¸¦ ¸¸µé°í ȯÀÚÀÇ °Ç°­°ú º¹Áö¸¦ º¸ÀåÇÏ´Â µ¥ ÇʼöÀûÀÎ µµ±¸ÀÔ´Ï´Ù.

½ÃÀå ¿ªÇÐ :

ÁÖ»ç °¡¹æ°ú °°Àº ¹«±Õ ÀÇ·á±â±â¿¡ ´ëÇÑ ¼ö¿ä Áõ°¡´Â ¸ê±Õ Æ©ºê ¹ÐºÀ±â¿¡ ´ëÇÑ ¼ö¿ä¸¦ ÁÖµµÇϰí ÀÖ½À´Ï´Ù. ÀÌ Àåºñ´Â ÀÇ·á±â±âÀÇ Æ©ºê ±¸¼º ¿ä¼Ò »çÀÌ¿¡ ¹ÐÆó µÈ ¸ê±Õ ¿¬°áÀ» Çü¼ºÇÏ´Â µ¥ »ç¿ëµË´Ï´Ù. »õ·Î¿î Àç·á¿Í ÄÚÆÃÀÇ °³¹ßÀº ¸ê±Õ Æ©ºê ¹ÐºÀ±â¿¡ ´ëÇÑ ¼ö¿ä¸¦ Áõ°¡½Ã۰í ÀÖ½À´Ï´Ù. ÀÌ·¯ÇÑ ¹ßÀüÀº Á¤È®ÇÏ°í ¹«±ÕÀûÀÎ ¿¬°áÀÌ ÇÊ¿äÇÑ ´õ Áøº¸µÈ »õ·Î¿î ÀÇ·á±â±âÀÇ °³¹ß·Î À̾îÁö°í ÀÖ½À´Ï´Ù. ÀÇ·á ºÐ¾ßÀÇ È®ÀåÀº ¸ê±Õ Æ©ºê ¹ÐºÀ±â¿¡ ´ëÇÑ ¼ö¿ä¸¦ ÁÖµµÇϰí ÀÖ½À´Ï´Ù. ÀÇ·á ºÐ¾ß°¡ È®´ëµÊ¿¡ µû¶ó ÀÇ·á Àåºñ¿¡ ´ëÇÑ ¼ö¿ä°¡ Áõ°¡Çϰí ÀÖÀ¸¸ç, ÀÌ´Â ¸ê±Õ Æ©ºê ¹ÐºÀ±â¿¡ ´ëÇÑ ¼ö¿ä¸¦ ÁÖµµÇϰí ÀÖ½À´Ï´Ù. ´ç´¢º´°ú ¾Ï ¹ßº´·ü Áõ°¡´Â ¸ê±Õ Æ©ºê ¹ÐºÀ±â¼ö¿ä¸¦ Áõ°¡½Ã۰í ÀÖ½À´Ï´Ù. ÀÌ·¯ÇÑ Áúº´Àº ºó¹øÇÑ ÀÇ·á °³ÀÔÀÌ ÇÊ¿äÇϸç, À̶§ ¹«±Õ ¿¬°áÀÌ ÇÊ¿äÇÑ ÀÇ·á±â±â¸¦ »ç¿ëÇÏ´Â °æ¿ì°¡ ¸¹±â ¶§¹®ÀÔ´Ï´Ù. °í·ÉÈ­ »çȸ°¡ ÁøÇàµÊ¿¡ µû¶ó ¾à¹° ¹× ¼ö¾× ÁÖÀÔÀ» À§ÇÑ ÁÖÀÔ ¹é µî ÀÇ·á Àåºñ¿¡ ´ëÇÑ ¼ö¿ä°¡ Áõ°¡ÇÔ¿¡ µû¶ó ¸ê±Õ Æ©ºê ¹ÐºÀ±â¿¡ ´ëÇÑ ¼ö¿ä°¡ Áõ°¡Çϰí ÀÖ½À´Ï´Ù.

ÀÌ º¸°í¼­´Â Porter's Five Forces ¸ðµ¨, ½ÃÀå ¸Å·Âµµ ºÐ¼®, ¹ë·ùüÀÎ ºÐ¼®¿¡ ´ëÇØ ¼³¸íÇÕ´Ï´Ù. ÀÌ·¯ÇÑ µµ±¸´Â »ê¾÷ ±¸Á¶¸¦ ¸íÈ®ÇÏ°Ô ÆÄ¾ÇÇÏ°í ¼¼°è ¼öÁØ¿¡¼­ °æÀïÀÇ ¸Å·Âµµ¸¦ Æò°¡ÇÏ´Â µ¥ µµ¿òÀÌ µË´Ï´Ù. ¶ÇÇÑ ÀÌ·¯ÇÑ µµ±¸´Â ¼¼°èÀÇ ¸ê±Õ Æ©ºê ¹ÐºÀ±â ½ÃÀå¿¡¼­ °¢ ºÎ¹®À» Á¾ÇÕÀûÀ¸·Î Æò°¡ÇÒ ¼ö ÀÖ½À´Ï´Ù. ¸ê±Õ Æ©ºê ¹ÐºÀ±â »ê¾÷ÀÇ ¼ºÀå°ú µ¿ÇâÀºÀÌ ¿¬±¸¿¡ ´ëÇÑ ÀüüÀûÀÎ Á¢±Ù ¹æ½ÄÀ» Á¦°øÇÕ´Ï´Ù.

½ÃÀå ¼¼ºÐÈ­ :

¸ê±Õ Æ©ºê ¹ÐºÀ±â ½ÃÀå ¼¼ºÐÈ­´Â ±¹°¡ ¹× Áö¿ªº°·Î »ó¼¼ÇÑ ºÎ¹® µ¥ÀÌÅ͸¦ Á¦°øÇÏ¿© Á¦Ç° ¹× ¼­ºñ½º Ÿ°ÙÃþ°ú ÇâÈÄ ºñÁî´Ï½º ±âȸ¸¦ ÆÄ¾ÇÇÒ ¼ö ÀÖµµ·Ï Áö¿øÇÕ´Ï´Ù.

¸ðµåº°

  • ¼öµ¿
  • ÀÚµ¿

¿ëµµº°

  • ¹ÙÀÌ¿ÀÀǾàǰ
  • Ç÷¾× ó¸®
  • Áø´Ü ½ÇÇè½Ç
  • ±âŸ

ÃÖÁ¾»ç¿ëÀÚº°

  • º´¿ø
  • ¿¬±¸±â°ü
  • Ç÷¾×¼¾ÅÍ
  • ±âŸ

Áö¿ªº° ºÐ¼® :

ÀÌ ¼½¼Ç¿¡¼­´Â ºÏ¹Ì, À¯·´, ¾Æ½Ã¾ÆÅÂÆò¾ç, ¶óƾ¾Æ¸Þ¸®Ä«, Áßµ¿ ¹× ¾ÆÇÁ¸®Ä«ÀÇ ¸ê±Õ Æ©ºê ¹ÐºÀ±â ½ÃÀåÀÇ ÇöÀç ¹× ¹Ì·¡ ¼ö¿ä¸¦ °­Á¶ÇÏ´Â Áö¿ª Àü¸ÁÀ» ´Ù·ì´Ï´Ù. ¶ÇÇÑ, ¸ðµç ÁÖ¿ä Áö¿ªÀÇ °³º° ¿ëµµ ºÎ¹® ¼ö¿ä, ÃßÁ¤ ¹× ¿¹Ãø¿¡ ÃÊÁ¡À» ¸ÂÃß°í ÀÖ½À´Ï´Ù.

ÀÌ º¸°í¼­´Â ¶ÇÇÑ ½ÃÀå ÁÖ¿ä ±â¾÷ÀÇ Á¾ÇÕÀûÀÎ ÇÁ·ÎÆÄÀϰú ¼¼°è °æÀï ȯ°æ¿¡ ´ëÇÑ ÀÚ¼¼ÇÑ Àü¸ÁÀ» ´Ù·ç°í ÀÖ½À´Ï´Ù. ¸ê±Õ Æ©ºê ¹ÐºÀ±â ½ÃÀåÀÇ ÁÖ¿ä ¾÷ü·Î´Â Sartorius Stedim Biotech S.A., Terumo BCT Inc. Company Ltd., Flex Concepts Inc., Shanghai Le Pure Biological Technology Co. ÀÌ ¼½¼ÇÀº ÁÖ¿ä M&A, ¹Ì·¡ ¿ª·®, ÆÄÆ®³Ê½Ê, À繫 °³¿ä, Çù¾÷, ½ÅÁ¦Ç° °³¹ß, ½ÅÁ¦Ç° Ãâ½Ã µî ´Ù¾çÇÑ Àü·«Àû ¹ßÀüÀ» Æ÷ÇÔÇÑ °æÀï ±¸µµÀÇ Àü¹ÝÀûÀÎ °³¿ä·Î ±¸¼ºµÇ¾î ÀÖ½À´Ï´Ù.

»ç¿ëÀÚ ÁöÁ¤ ¿ä±¸ »çÇ×ÀÌ ÀÖ´Â °æ¿ì ´ç»ç¿¡ ¹®ÀÇÇϽʽÿÀ. ´ç»çÀÇ Á¶»ç ÆÀÀº ±ÍÇÏÀÇ Çʿ信 µû¶ó ¸ÂÃãÇü º¸°í¼­¸¦ Á¦°øÇÒ ¼ö ÀÖ½À´Ï´Ù.

¸ñÂ÷

Á¦1Àå ¼­¹®

  • º» º¸°í¼­ÀÇ ³»¿ë
    • ¸ñÀû
    • ´ë»ó µ¶ÀÚ
    • Unique Selling Proposition(USP) ¹× Á¦°ø ¼­ºñ½º
  • Á¶»ç ¹üÀ§
  • Á¶»ç ¹æ¹ý
    • ½ÃÀå Á¶»ç °úÁ¤
    • ½ÃÀå Á¶»ç ¹æ¹ý

Á¦2Àå ÁÖ¿ä ¿ä¾à

  • ½ÃÀå ÇÏÀ̶óÀÌÆ®
  • ¼¼°è ½ÃÀå ½º³À¼ô

Á¦3Àå ¸ê±Õ Æ©ºê ¹ÐºÀ±â - »ê¾÷ ºÐ¼®

  • ¼­·Ð - ½ÃÀå ¿ªÇÐ
  • ½ÃÀå ¼ºÀå ÃËÁø¿äÀÎ
  • ½ÃÀå ¼ºÀå ¾ïÁ¦¿äÀÎ
  • ½ÃÀå ±âȸ
  • »ê¾÷ µ¿Çâ
  • PorterÀÇ Five Forces ºÐ¼®
  • ½ÃÀå ¸Å·Âµµ ºÐ¼®
    • ½ÃÀåÀÇ ¸Å·Â ºÐ¼® : ¸ðµåº°
    • ½ÃÀ庰 ¸Å·Â ºÐ¼® : ¿ëµµº°
    • ½ÃÀ庰 ¸Å·Â ºÐ¼® : ÃÖÁ¾ ¿ëµµº°
    • ½ÃÀ庰 ¸Å·Â ºÐ¼® : Áö¿ªº°

Á¦4Àå ¹ë·ùüÀÎ ºÐ¼®

  • ¹ë·ùüÀÎ ºÐ¼®
  • ¿øÀç·á ºÐ¼®
    • ¿øÀç·á ¸®½ºÆ®
    • ¿øÀç·á Á¦Á¶¾÷ü ¸®½ºÆ®
    • ÁÖ¿ä ¿øÀç·á °¡°Ý µ¿Çâ
  • ÀáÀçÀû ±¸¸ÅÀÚ ¸®½ºÆ®
  • ¸¶ÄÉÆÃ Ã¤³Î
    • Á÷Á¢ ¸¶ÄÉÆÃ
    • °£Á¢ ¸¶ÄÉÆÃ
    • ¸¶ÄÉÆÃ Ã¤³Î µ¿Çâ

Á¦5Àå COVID-19 ¹ß»ý¿¡ ÀÇÇÑ ¿µÇ⠺м®

Á¦6Àå ¼¼°èÀÇ ¸ê±Õ Æ©ºê ¹ÐºÀ±â ½ÃÀå ºÐ¼® : ¸ðµåº°

  • ¸ðµåº° °³¿ä
  • ½ÇÀû µ¥ÀÌÅÍ¿Í ¿¹Ãø µ¥ÀÌÅÍ
  • ¸ðµåº° ºÐ¼®
  • ¼öµ¿
  • ÀÚµ¿

Á¦7Àå ¼¼°èÀÇ ¸ê±Õ Æ©ºê ¹ÐºÀ±â ½ÃÀå ºÐ¼® : ¿ëµµº°

  • °³¿ä : ¿ëµµº°
  • °ú°Å ¹× ¹Ì·¡ µ¥ÀÌÅÍ
  • ºÐ¼® : ¿ëµµº°
  • ¹ÙÀÌ¿ÀÀǾàǰ
  • Ç÷¾× ó¸®
  • Áø´Ü ½ÇÇè½Ç
  • ±âŸ

Á¦8Àå ¼¼°èÀÇ ¸ê±Õ Æ©ºê ¹ÐºÀ±â ½ÃÀå ÆÇ¸Å ºÐ¼® : ÃÖÁ¾ ¿ëµµº°

  • ÃÖÁ¾ ¿ëµµº° °³¿ä
  • °ú°Å ¹× ¹Ì·¡ µ¥ÀÌÅÍ
  • ÃÖÁ¾ ¿ëµµº° ºÐ¼®
  • º´¿ø
  • ¿¬±¸±â°ü
  • Ç÷¾×¼¾ÅÍ
  • ±âŸ

Á¦9Àå ¼¼°èÀÇ ¸ê±Õ Æ©ºê ¹ÐºÀ±â ½ÃÀå ÆÇ¸Å ºÐ¼® : Áö¿ªº°

  • Áö¿ªº° ÆÇ¸Å ºÐ¼®
  • ¼­·Ð ÆÇ¸Å ºÐ¼®
  • ºÏ¹Ì ÆÇ¸Å ºÐ¼®
    • °³¿ä, °ú°Å ¹× ÇâÈÄ ÆÇ¸Å ºÐ¼®
    • ºÏ¹Ì ºÎ¹®º° ÆÇ¸Å ºÐ¼®
    • ºÏ¹Ì ±¹°¡º° ÆÇ¸Å ºÐ¼®
    • ¹Ì±¹ ÆÇ¸Å ºÐ¼®
    • ij³ª´Ù ÆÇ¸Å·® ºÐ¼®
    • ¸ß½ÃÄÚ ÆÇ¸Å ºÐ¼®
  • À¯·´ ÆÇ¸Å·® ºÐ¼®
    • °³¿ä, °ú°Å ¹× ÇâÈÄ ÆÇ¸Å ºÐ¼®
    • À¯·´ ºÎ¹®º° ÆÇ¸Å ºÐ¼®
    • À¯·´ ±¹°¡º° ÆÇ¸Å ºÐ¼®
    • ¿µ±¹ ÆÇ¸Å·® ºÐ¼®
    • ÇÁ¶û½º ÆÇ¸Å·® ºÐ¼®
    • µ¶ÀÏ ÆÇ¸Å ºÐ¼®
    • ÀÌÅ»¸®¾Æ ÆÇ¸Å ºÐ¼®
    • ·¯½Ã¾Æ ÆÇ¸Å·® ºÐ¼®
    • ±âŸ À¯·´ ÆÇ¸Å·® ºÐ¼®
  • ¾Æ½Ã¾ÆÅÂÆò¾ç ÆÇ¸Å ºÐ¼®
    • °³¿ä, °ú°Å ¹× ÇâÈÄ ÆÇ¸Å·® ºÐ¼®
    • ¾Æ½Ã¾ÆÅÂÆò¾ç ºÎ¹®º° ÆÇ¸Å ºÐ¼®
    • ¾Æ½Ã¾ÆÅÂÆò¾ç ±¹°¡º° ÆÇ¸Å ºÐ¼®
    • Áß±¹ ÆÇ¸Å ºÐ¼®
    • Àεµ ÆÇ¸Å ºÐ¼®
    • ÀϺ» ÆÇ¸Å ºÐ¼®
    • Çѱ¹ ÆÇ¸Å ºÐ¼®
    • È£ÁÖ ÆÇ¸Å·® ºÐ¼®
    • ±âŸ ¾Æ½Ã¾ÆÅÂÆò¾ç ÆÇ¸Å·® ºÐ¼®
  • ¶óƾ¾Æ¸Þ¸®Ä« ÆÇ¸Å ºÐ¼®
    • °³¿ä, °ú°Å ¹× ÇâÈÄ ÆÇ¸Å·® ºÐ¼®
    • ¶óƾ¾Æ¸Þ¸®Ä« ºÎ¹®º° ÆÇ¸Å ºÐ¼®
    • ¶óƾ¾Æ¸Þ¸®Ä« ±¹°¡º° ÆÇ¸Å ºÐ¼®
    • ºê¶óÁú ÆÇ¸Å ºÐ¼®
    • ¾Æ¸£ÇîÆ¼³ª ÆÇ¸Å·® ºÐ¼®
    • Æä·ç ÆÇ¸Å ºÐ¼®
    • Ä¥·¹ ÆÇ¸Å ºÐ¼®
    • ±âŸ ¶óƾ¾Æ¸Þ¸®Ä« ÆÇ¸Å ºÐ¼®
  • Áßµ¿ ¹× ¾ÆÇÁ¸®Ä« ÆÇ¸Å ºÐ¼®
    • °³¿ä, °ú°Å ¹× ÇâÈÄ ÆÇ¸Å·® ºÐ¼®
    • Áßµ¿ ¹× ¾ÆÇÁ¸®Ä« ºÎ¹®º° ÆÇ¸Å ºÐ¼®
    • Áßµ¿ ¹× ¾ÆÇÁ¸®Ä« ±¹°¡º° ÆÇ¸Å ºÐ¼®
    • »ç¿ìµð¾Æ¶óºñ¾Æ ÆÇ¸Å ºÐ¼®
    • ¾Æ¶ø¿¡¹Ì¸®Æ®(UAE) ÆÇ¸Å·® ºÐ¼®
    • À̽º¶ó¿¤ ÆÇ¸Å·® ºÐ¼®
    • ³²¾ÆÇÁ¸®Ä«°øÈ­±¹ ÆÇ¸Å ºÐ¼®
    • ±âŸ Áßµ¿ ¹× ¾ÆÇÁ¸®Ä« ÆÇ¸Å ºÐ¼®

Á¦10Àå ¸ê±Õ Æ©ºê ¹ÐºÀ±â ±â¾÷ °æÀï ±¸µµ

  • ¸ê±Õ Æ©ºê ¹ÐºÀ±â ½ÃÀå °æÀï
  • ÆÄÆ®³Ê½Ê/Çù·Â/°è¾à
  • ÀμöÇÕº´(M&A)
  • ½ÅÁ¦Ç° ¹ß¸Å
  • ±âŸ °³¹ß

Á¦11Àå ±â¾÷ °³¿ä

  • ÁÖ¿ä 10°³»çÀÇ Á¡À¯À² ºÐ¼®
  • ½ÃÀå ÁýÁßµµ
  • Sartorius Stedim Biotech S.A.
    • ±â¾÷ °³¿ä
    • ±â¾÷ ¼öÀÍ
    • Á¦Ç° ¼Ò°³
    • ÃÖ±Ù °³¹ß »óȲ
  • Terumo BCT Inc.
    • ±â¾÷ °³¿ä
    • ±â¾÷ ¼öÀÍ
    • Á¦Ç° Á¤º¸
    • ÃÖ±Ù °³¹ß »óȲ
  • GE Healthcare
    • ±â¾÷ °³¿ä
    • ±â¾÷ ¼öÀÍ
    • Á¦Ç° Á¤º¸
    • ÃÖ±Ù °³¹ß »óȲ
  • MGA technologies
    • ±â¾÷ °³¿ä
    • ±â¾÷ ¼öÀÍ
    • Á¦Ç° Á¤º¸
    • ÃÖ±Ù °³¹ß »óȲ
  • VANTE Biopharm
    • ±â¾÷ °³¿ä
    • ±â¾÷ ¼öÀÍ
    • Á¦Ç° Á¤º¸
    • ÃÖ±Ù °³¹ß »óȲ
  • Genesis BPS
    • ±â¾÷ °³¿ä
    • ±â¾÷ ¼öÀÍ
    • Á¦Ç° Á¤º¸
    • ÃÖ±Ù °³¹ß »óȲ
  • Biomen Biosystems Company Ltd.
    • ±â¾÷ °³¿ä
    • ±â¾÷ ¼öÀÍ
    • Á¦Ç° Á¤º¸
    • ÃÖ±Ù °³¹ß »óȲ
  • Flex Concepts Inc.
    • ±â¾÷ °³¿ä
    • ±â¾÷ ¼öÀÍ
    • Á¦Ç° Á¤º¸
    • ÃÖ±Ù °³¹ß »óȲ
  • Shanghai Le Pure Biological Technology Co. Ltd.
    • ±â¾÷ °³¿ä
    • ±â¾÷ ¼öÀÍ
    • Á¦Ç° Á¤º¸
    • ÃÖ±Ù µ¿Çâ

ÁÖ : ±â¾÷ °³¿ä Áß¿¡¼­ À繫 »ó¼¼³ª ÃÖ±Ù °³¹ß¿¡ °ü·ÃµÈ °ÍÀº ÀÔ¼ö °¡´ÉÇÑ Á¤º¸¿¡ ±Ù°ÅÇÑ °ÍÀ̸ç, ºñ°ø°³ ±â¾÷ÀÇ °æ¿ì °ÔÀçµÇÁö ¾ÊÀ» ¼ö ÀÖ½À´Ï´Ù.

LSH 23.06.02

The global demand for Sterile Tubing Welders Market is presumed to reach the market size of nearly USD 12.72 BN by 2030 from USD 6.42 BN in 2022 with a CAGR of 8.92% under the study period 2023 - 2030.

Sterile Tubing Welders are devices used to create sealed, sterile connections between tubing components in medical devices, such as intravenous (IV) bags. The connections created by these welders are critical to maintaining the sterility of the medical devices and ensuring the safety of the patients. Sterile tubing welders use heat, pressure, or a combination of both to create the connections. They are designed to meet strict sterilization and cleanliness requirements, and they are typically used in sterile environments, such as operating rooms and clean rooms. Sterile tubing welders are an important component of the medical device manufacturing process and play a critical role in ensuring the safety and efficacy of medical devices. These welders are used in a wide range of medical applications, including the administration of medications, fluid delivery, and blood transfusions. Overall, sterile tubing welders are an essential tool for creating safe, effective medical devices and for ensuring the health and well-being of patients. 

Market Dynamics:

The increasing demand for sterile medical devices, such as IV bags, is driving the demand for sterile tubing welders. These devices are used to create sealed, sterile connections between tubing components in medical devices. The development of new materials and coatings is driving the demand for sterile tubing welders. These advances are leading to the development of new, more advanced medical devices that require precise, sterile connections. The growing healthcare sector is driving the demand for sterile tubing welders. As the healthcare sector continues to expand, there is an increasing demand for medical devices, which in turn is driving the demand for sterile tubing welders. The rising incidence of diabetes and cancer is driving the demand for sterile tubing welders. These diseases require frequent medical interventions, which are often performed using medical devices that require sterile connections. The ageing population is growing, which is driving the demand for sterile tubing welders, as there is an increasing demand for medical devices, such as IV bags, which are used to administer medications and fluids.

The research report covers Porter's Five Forces Model, Market Attractiveness Analysis, and Value Chain analysis. These tools help to get a clear picture of the industry's structure and evaluate the competition attractiveness at a global level. Additionally, these tools also give an inclusive assessment of each segment in the global market of sterile tubing welders. The growth and trends of sterile tubing welders industry provide a holistic approach to this study. 

Market Segmentation:

This section of the sterile tubing welders market report provides detailed data on the segments at country and regional level, thereby assisting the strategist in identifying the target demographics for the respective product or services with the upcoming opportunities. 

By Mode

  • Manual
  • Automatic

By Application

  • Biopharmaceutical
  • Blood Processing
  • Diagnostic Laboratories
  • Others

By End-Use

  • Hospitals
  • Research Clinics
  • Blood Centers
  • Others

Regional Analysis:

This section covers the regional outlook, which accentuates current and future demand for the Sterile Tubing Welders market across North America, Europe, Asia-Pacific, Latin America, and Middle East & Africa. Further, the report focuses on demand, estimation, and forecast for individual application segments across all the prominent regions.

The research report also covers the comprehensive profiles of the key players in the market and an in-depth view of the competitive landscape worldwide. The major players in the sterile tubing welders market include Sartorius Stedim Biotech S.A., Terumo BCT Inc., GE Healthcare, MGA technologies, VANTE Biopharm, Genesis BPS, Biomen Biosystems Company Ltd., Flex Concepts Inc., Shanghai Le Pure Biological Technology Co. Ltd. This section consists of a holistic view of the competitive landscape that includes various strategic developments such as key mergers & acquisitions, future capacities, partnerships, financial overviews, collaborations, new product developments, new product launches, and other developments.

In case you have any custom requirements, do write to us. Our research team can offer a customized report as per your need.

TABLE OF CONTENTS

1 . PREFACE

  • 1.1. Report Description
    • 1.1.1. Objective
    • 1.1.2. Target Audience
    • 1.1.3. Unique Selling Proposition (USP) & offerings
  • 1.2. Research Scope
  • 1.3. Research Methodology
    • 1.3.1. Market Research Process
    • 1.3.2. Market Research Methodology

2 . EXECUTIVE SUMMARY

  • 2.1. Highlights of Market
  • 2.2. Global Market Snapshot

3 . STERILE TUBING WELDERS - INDUSTRY ANALYSIS

  • 3.1. Introduction - Market Dynamics
  • 3.2. Market Drivers
  • 3.3. Market Restraints
  • 3.4. Opportunities
  • 3.5. Industry Trends
  • 3.6. Porter's Five Force Analysis
  • 3.7. Market Attractiveness Analysis
    • 3.7.1 Market Attractiveness Analysis By Mode
    • 3.7.2 Market Attractiveness Analysis By Application
    • 3.7.3 Market Attractiveness Analysis By End-use
    • 3.7.4 Market Attractiveness Analysis By Region

4 . VALUE CHAIN ANALYSIS

  • 4.1. Value Chain Analysis
  • 4.2. Raw Material Analysis
    • 4.2.1. List of Raw Materials
    • 4.2.2. Raw Material Manufactures List
    • 4.2.3. Price Trend of Key Raw Materials
  • 4.3. List of Potential Buyers
  • 4.4. Marketing Channel
    • 4.4.1. Direct Marketing
    • 4.4.2. Indirect Marketing
    • 4.4.3. Marketing Channel Development Trend

5 . IMPACT ANALYSIS OF COVID-19 OUTBREAK

6 . GLOBAL STERILE TUBING WELDERS MARKET ANALYSIS BY MODE

  • 6.1 Overview by Mode
  • 6.2 Historical and Forecast Data
  • 6.3 Analysis by Mode
  • 6.4 Manual Historic and Forecast Sales by Regions
  • 6.5 Automatic Historic and Forecast Sales by Regions

7 . GLOBAL STERILE TUBING WELDERS MARKET ANALYSIS BY APPLICATION

  • 7.1 Overview by Application
  • 7.2 Historical and Forecast Data
  • 7.3 Analysis by Application
  • 7.4 Biopharmaceutical Historic and Forecast Sales by Regions
  • 7.5 Blood Processing Historic and Forecast Sales by Regions
  • 7.6 Diagnostic Laboratories Historic and Forecast Sales by Regions
  • 7.7 Others Historic and Forecast Sales by Regions

8 . GLOBAL STERILE TUBING WELDERS MARKET SALES ANALYSIS BY END-USE

  • 8.1 Overview by End-use
  • 8.2 Historical and Forecast Data
  • 8.3 Analysis by End-use
  • 8.4 Hospitals Historic and Forecast Sales by Regions
  • 8.5 Research Clinics Historic and Forecast Sales by Regions
  • 8.6 Blood Centers Historic and Forecast Sales by Regions
  • 8.7 Others Historic and Forecast Sales by Regions

9 . GLOBAL STERILE TUBING WELDERS MARKET SALES ANALYSIS BY GEOGRAPHY

  • 9.1. Regional Outlook Sales Analysis
  • 9.2. Introduction Sales Analysis
  • 9.3. North America Sales Analysis
    • 9.3.1. Overview, Historic and Forecast Sales Analysis
    • 9.3.2. North America By Segment Sales Analysis
    • 9.3.3. North America By Country Sales Analysis
    • 9.3.4. United State Sales Analysis
    • 9.3.5. Canada Sales Analysis
    • 9.3.6. Mexico Sales Analysis
  • 9.4. Europe Sales Analysis
    • 9.4.1. Overview, Historic and Forecast Sales Analysis
    • 9.4.2. Europe by Segment Sales Analysis
    • 9.4.3. Europe by Country Sales Analysis
    • 9.4.4. United Kingdom Sales Analysis
    • 9.4.5. France Sales Analysis
    • 9.4.6. Germany Sales Analysis
    • 9.4.7. Italy Sales Analysis
    • 9.4.8. Russia Sales Analysis
    • 9.4.9. Rest Of Europe Sales Analysis
  • 9.5. Asia Pacific Sales Analysis
    • 9.5.1. Overview, Historic and Forecast Sales Analysis
    • 9.5.2. Asia Pacific by Segment Sales Analysis
    • 9.5.3. Asia Pacific by Country Sales Analysis
    • 9.5.4. China Sales Analysis
    • 9.5.5. India Sales Analysis
    • 9.5.6. Japan Sales Analysis
    • 9.5.7. South Korea Sales Analysis
    • 9.5.8. Australia Sales Analysis
    • 9.5.9. Rest Of Asia Pacific Sales Analysis
  • 9.6. Latin America Sales Analysis
    • 9.6.1. Overview, Historic and Forecast Sales Analysis
    • 9.6.2. Latin America by Segment Sales Analysis
    • 9.6.3. Latin America by Country Sales Analysis
    • 9.6.4. Brazil Sales Analysis
    • 9.6.5. Argentina Sales Analysis
    • 9.6.6. Peru Sales Analysis
    • 9.6.7. Chile Sales Analysis
    • 9.6.8. Rest of Latin America Sales Analysis
  • 9.7. Middle East & Africa Sales Analysis
    • 9.7.1. Overview, Historic and Forecast Sales Analysis
    • 9.7.2. Middle East & Africa by Segment Sales Analysis
    • 9.7.3. Middle East & Africa by Country Sales Analysis
    • 9.7.4. Saudi Arabia Sales Analysis
    • 9.7.5. UAE Sales Analysis
    • 9.7.6. Israel Sales Analysis
    • 9.7.7. South Africa Sales Analysis
    • 9.7.8. Rest Of Middle East And Africa Sales Analysis

10 . COMPETITIVE LANDSCAPE OF THE STERILE TUBING WELDERS COMPANIES

  • 10.1. Sterile Tubing Welders Market Competition
  • 10.2. Partnership/Collaboration/Agreement
  • 10.3. Merger And Acquisitions
  • 10.4. New Product Launch
  • 10.5. Other Developments

11 . COMPANY PROFILES OF STERILE TUBING WELDERS INDUSTRY

  • 11.1. Top 10 Company Share Analysis
  • 11.2. Market Concentration Rate
  • 11.3. Sartorius Stedim Biotech S.A.
    • 11.3.1. Company Overview
    • 11.3.2. Company Revenue
    • 11.3.3. Products
    • 11.3.4. Recent Developments
  • 11.4. Terumo BCT Inc.
    • 11.4.1. Company Overview
    • 11.4.2. Company Revenue
    • 11.4.3. Products
    • 11.4.4. Recent Developments
  • 11.5. GE Healthcare
    • 11.5.1. Company Overview
    • 11.5.2. Company Revenue
    • 11.5.3. Products
    • 11.5.4. Recent Developments
  • 11.6. MGA technologies
    • 11.6.1. Company Overview
    • 11.6.2. Company Revenue
    • 11.6.3. Products
    • 11.6.4. Recent Developments
  • 11.7. VANTE Biopharm
    • 11.7.1. Company Overview
    • 11.7.2. Company Revenue
    • 11.7.3. Products
    • 11.7.4. Recent Developments
  • 11.8. Genesis BPS
    • 11.8.1. Company Overview
    • 11.8.2. Company Revenue
    • 11.8.3. Products
    • 11.8.4. Recent Developments
  • 11.9. Biomen Biosystems Company Ltd.
    • 11.9.1. Company Overview
    • 11.9.2. Company Revenue
    • 11.9.3. Products
    • 11.9.4. Recent Developments
  • 11.10. Flex Concepts Inc.
    • 11.10.1. Company Overview
    • 11.10.2. Company Revenue
    • 11.10.3. Products
    • 11.10.4. Recent Developments
  • 11.11. Shanghai Le Pure Biological Technology Co. Ltd.
    • 11.11.1. Company Overview
    • 11.11.2. Company Revenue
    • 11.11.3. Products
    • 11.11.4. Recent Developments

Note - in company profiling, financial details and recent development are subject to availability or might not be covered in case of private companies

ºñ±³¸®½ºÆ®
0 °ÇÀÇ »óǰÀ» ¼±Åà Áß
»óǰ ºñ±³Çϱâ
Àüü»èÁ¦